Osteomyelitis is one of the refractory diseases encountered in orthopedics, while Staphylococcus aureus (S. aureus) is the most common causative organism in osteomyelitis. However, the precise mechanisms underlying the bone loss caused by S. aureus infection have not been well defined. Here, we investigated the effect of S. aureus on osteoclast differentiation and the probable molecular mechanism. Material/Methods: RAW 264.7 cells were treated for 5 days with live S. aureus, inactivated S. aureus, and S. aureus filtrate. Then, the formation of osteoclast-like cells and resorption pits was observed, and the expression of osteoclast-specific genes (TRAP, MMP-9, cathepsin K, CTR and Atp6v0d2) was detected by real-time PCR. Moreover, key proteins in the signaling pathway associated with osteoclast differentiation were detected with Western blot.
Background
Osteomyelitis is an infectious disease of the bones, which is characterized by severe inflammation and progressive bone destruction [1] . With the increase of open fractures and orthopedic procedures, the incidence of osteomyelitis is significantly increasing [2] . However, due to lack of effective management, osteomyelitis causes serious morbidity and causes a great deal of physical and psychological damage to patients [3] . Staphylococcus aureus (S. aureus) is the most common causative organism in osteomyelitis [4, 5] , and accounts for approximately 80% of all osteomyelitis cases [6] . S. aureus infection usually leads to excessive bone destruction and results in bone defects [7, 8] , but the precise mechanisms underlying the bone loss caused by S. aureus infection are not well understood.
Bone is a dynamic organ, which is constantly remodeled by osteoblasts (mediating bone formation) and osteoclasts (mediating bone resorption) [9] , and the balance between bone formation and bone resorption plays a major role in the maintenance of bone mineralization [10] . As to the mechanisms of bone loss caused by S. aureus infection, a large number of studies focused on the direct effects of S. aureus on bone formation [11] . It is clear that S. aureus reduces osteogenic differentiation from marrow mesenchymal stem cells [12] and induces cell apoptosis and death of osteoblasts [13, 14] . Moreover, S. aureus inhibits osteoblast proliferation and bone mineralization by producing virulence factors: staphylococcal protein A, Panton-Valentine leukocidin, and coagulase [15] . However, with respect to bone resorption, the direct effects of S. aureus on osteoclasts have been poorly studied. Some studies have explored the direct effect of S. aureus capsular material [16] [17] [18] or its components (such as lipoteichoic acid [19, 20] , peptidoglycan [21, 22] ) on osteoclasts, but the results are controversial due to the different methods and osteoclast precursors used in the experiments. Moreover, as the most common pathogenic bacteria in osteomyelitis, S. aureus is able to synthesize a large number of virulence factors, except for the cytotoxic components of the cell wall, and the effects of S. aureus on osteoclasts are caused by the combination of these virulence factors. Therefore, we took RAW 264.7cell line as osteoclast precursors, which is internationally recognized and widely used in studies of osteoclast differentiation [23] . We treated RAW 264.7 cells with live S. aureus, inactivated S. aureus, and S. aureus filtrate to investigate the effects of S. aureus on osteoclastogenesis. In addition, we explored the underlying mechanism of S. aureus -induced osteoclastogenesis, and the results indicated that S. aureus promoted osteoclastogenesis through its cell wall compound and secretion of small soluble molecules, and we found that the NF-kB signaling pathway plays a role in this process.
Material and Methods

Chemicals
Penicillin-Streptomycin solution and high-glucose Dulbecco's modified Eagle's medium (DMEM) were purchased from Hyclone (USA); fetal bovine serum (FBS) was purchased from Gibco (USA); acid phosphatase leukocyte kit (TRAP, 387A) and methyl thiazolyl tetrazolium (MTT) were obtained from SigmaAldrich Co. (USA). JSH-23 (Cat. No. S7351) was from Selleck Chemicals; soluble receptor-activated nuclear factor kB ligand (RANKL) was obtained from R&D Systems (USA); and the GeneJET RNA purification kit was purchased from Thermo Scientific (USA). PrimeScript™ RT reagent kit with gDNA Eraser (Perfect Real Time) and SYBR ® Premix Ex Taq™ II (Tli RNaseH Plus) were purchased from Takara Bio Co., Ltd. (Dalian, China). Oligonucleotide primer sets were synthesized by AuGCT DNA-SYN Biotechnology Synthesis Lab Co., Ltd. (Beijing, China). Immobilon Western Chemiluminescent HRP substrate and polyvinylidene difluoride (PVDF) membranes were purchased from Millipore (Germany). Antibodies against IkB-a, NF-kB p65, Akt, p38, ERK1/2, JNK, NFATc1, and GAPDH, or the phosphorylated form of NF-kB p65, Akt, p38, ERK1/2, JNK, and HRPlinked rabbit IgG antibody were purchased from Cell Signaling Technology (USA). IL-1a (Interleukin-1 alpha) mouse in vitro SimpleStep ELISA™ kit, Mouse TNF alpha SimpleStep ELISA ® kit and IL-6 (Interleukin-6) mouse ELISA kit were purchased from Abcam (England).
S. aureus culture
The S. aureus (ATCC43300) culture was performed following the protocols reported in our previous study [15] . In brief, S. aureus was grown overnight in tryptic soy broth at 37°C with shaking, and then S. aureus was harvested by centrifugation and resuspended in phosphate-buffered saline (PBS). The tablet colony counting method was used to count the number of S. aureus in suspension. Inactivated S. aureus was prepared by exposing the counted live S. aureus to a temperature of 95°C for 20 min. The S. aureus filtrate was prepared by culturing live S. aureus in high-glucose Dulbecco's modified Eagle's medium in the upper compartment of a Transwell bicameral chamber with a 0.4-mm pore size polycarbonate filter (Corning, New York, USA), which permits small soluble molecules produced by S. aureus to penetrate into the lower compartment, and the concentration of S. aureus filtrate was roughly determined by BCA protein assay kit (Beyotime, Shanghai, China).
Cell culture RAW 264.7 mouse monocytes/macrophage cell line (TIB-71; ATCC) was used as osteoclast precursors, the cells were grown in high-glucose DMEM, supplemented with 10% fetal bovine serum and 1% Penicillin-Streptomycin solution, and in a humidified atmosphere of 95% air and 5% CO 2 at 37°C; the media were changed every 3 days.
Cell viability assay (MTT assay)
RAW 264.7 cells were plated in 96-well plates at a density of 5×10 3 and 20 μg/ml), and equal volume of PBS (control) for 1, 3, and 5 days; the media and stimuli were changed every 3 days. Note that live S. aureus infected RAW264.7 cells for 24 h, and then were inactivated with sensitive antibiotics, and RAW264.7 cells were cultured to a predetermined time. After culturing at indicated days, the cells were added with 10 μl MTT solution and incubated at 37°C for 4 h in the dark. Then, the media were removed, and the plates were added with 100 μl dimethyl sulfoxide solution and shaken for 10 min. Subsequently, the optical density (OD) values of every well were detected with a microplate reader (Model 680, BIO-RAD, USA) at 570 nm.
In vitro osteoclastogenetic assays
To differentiate into osteoclasts, RAW 264.7 cells were seeded in 96-well plates at a density of 5×10 3 aureus was removed with sensitive antibiotics, and the cells were cultured for another 4 days. After culturing at indicated days, the cells were harvested and the total RNA was isolated with the GeneJET RNA purification kit according to the manufacturer's procedure, and the concentration of total RNA was measured with a microspectrophotometer (NanoDrop 2000, Thermo Scientific, USA). Total RNA of 500 ng was used to synthesize to cDNA by reverse transcription using PrimeScript™ RT reagent kit with gDNA Eraser. Real-time PCR was performed in CFX96 Real-time System (BIO-RAD, USA) with a SYBR ® Premix Ex Taq™. Reactions were initiated by incubation at 94°C for 5 min, and PCR (94°C for 30 s, 60°C (58°C for GAPDH) for 34 s and 72 o C for 30 s) was performed for 40 cycles; all reactions were performed in triplicate. Relative quantities of the tested genes were normalized to GAPDH mRNA, and the normalized data are expressed using the comparative 2 -DDCT method. The primer sets used in experiments are shown in Table 1 . NF-kB and NFATc1, JSH-23 was added 1 h ahead of live S. aureus, and left for 24 h. At the indicated time, the cells were harvested and lysed using high-efficiency RIPA tissue/cell lysis solution (Solarbio, Beijing, China). After centrifugation, the proteins in the supernatant were collected. Subsequently, protein concentration was measured by a BCA protein assay kit (Beyotime, Shanghai, China), and protein samples were mixed with the sample buffer and boiled for 5 min. After that, protein samples (20 μg) were loaded onto 8-12% polyacrylamide gels, transferred to PVDF membranes subsequently blocked with 5% skimmed milk or BSA TBS (0.05% Tween-20) for 1 hat room temperature, and then were probed with specific antibodies against total ERK1/2, p38, JNK, NF-kB p65, IkB-a, Akt, GAPDH, and NFATc1, or the phosphorylated form of ERK1/2, p38, JNK, NF-kB p65, and Akt. Detection was carried out using HRP-linked rabbit IgG antibody, followed by ECL Western blotting detection reagents, and the densitometer scans of the blots were performed using the Universal Hood 2 Electrophoresis Imaging Cabinet (Bio-Rad, USA).
Data analysis
Each experiment was repeated in triplicate and similar results were obtained. Results are expressed as the mean ±SD. SPSS 19.0 software was used for statistical analysis, and the statistical significance was determined by one-way analysis of variance (ANOVA) with LSD/Student-Newman-Keul test; and p<0.05 was considered statistically significant.
Results
Effects of live S. aureus, inactivated S. aureus, and S. aureus filtrate on cell viability
The cytotoxic effects of live S. aureus, inactivated S. aureus, and S. aureus filtrate on RAW 264.7 cells were measured by MTT assay. As shown in Figure 1 , the MOIs of inactivated S. aureus The excessively increased osteoclast activity is closely related to a variety of osteolytic diseases, such as rheumatoid arthritis, osteomyelitis, and periodontitis [24] . Therefore, we explored the effect of S. aureus on osteoclast formation through 3 aspects of live S. aureus, inactivated S. aureus, and S. aureus filtrate. As shown in Figures 2 and 3 (Figure 4 ). The area of resorption pits induced by RANKL was the largest ( Figures 4, 5) ; and live S. aureus, inactivated S. aureus, and S. aureus filtrate induced the formation of resorption pits in a dose-dependent manner in the absence of RANKL ( (Figures 4, 5) . However, when pretreated with JSH-23, the formation of resorption pits induced by live S. aureus, inactivated S. aureus, and S. aureus filtrate was obviously decreased (Figures 4, 5) . Collectively, S. aureus promoted bone resorption through its cell wall compound and secretion of small soluble molecules, but JSH-23 inhibited this promotion effect.
S. aureus increased the mRNA expression levels of osteoclast-specific genes in RAW 264.7 cells
Osteoclasts originated from hematopoietic cells of the monocyte/macrophage family [26] and RAW 264.7 cells have been shown to differentiate into mature osteoclasts when treated with RANKL [26, 27] . Even in the absence of RANKL, LIGHT, IL-6 and TNF-a can induce RAW264.7 cells to differentiate into mature osteoclasts [28] . To verify the effect of S. aureus in promoting osteoclastogenesis in RAW264.7cells, we measured the mRNA expression levels of osteoclast-specific genes, such as TRAP, MMP-9, cathepsin K, CTR, and Atp6v0d2. As shown in Figure 6 , RAW 264.7 cells themselves had the mRNA expression of TRAP, MMP-9, cathepsin K, CTR, and Atp6v0d2. Moreover, live S. aureus, inactivated S. aureus, and S. aureus filtrate increased the mRNA expression of osteoclast-specific genes in RAW 264.7 cells in a dose-dependent manner. However, when JSH-23 was added, the expression of osteoclast-specific genes induced by live S. aureus, inactivated S. aureus, and S. aureus filtrate were obviously decreased.
S. aureus induced osteoclast differentiation through the activation of NF-kB and the increased expression of NFATc1
It was reported that NF-kB [29] , 3 mitogen-activated protein kinases (MAPKs, including p38, ERK and JNK) [30] , and PI-3K/ Akt [31] signaling pathways are involved in osteoclast differentiation. To elucidate the signaling pathways by which S. aureus promotes osteoclast differentiation, we measured the protein expression levels of these signaling pathways and NFATc1 in RAW 264.7 cells stimulated by live S. aureus. As shown in Figure 7 , the degradation of IkBa occurred at 10 min after live S. aureus treatment ( Figure 7A, 7C) , while the phosphorylation of NF-kB p65 rose markedly at 5 and 10 min ( Figure 7A, 7D) . Moreover, proteins in the signaling pathways of Akt and MAPKs showed no obvious change when treated with live S. aureus ( Figure 7A ).
The nuclear factor of activated T cells (NFATc1) is an important transcription factor in osteoclast differentiation; the induction of NFATc1 is a hallmark event in the cell terminal determination of osteoclasts [32, 33] ; and the presence of NFATc1 in osteoclast precursors could promote them to differentiate into mature osteoclasts in the absence of RANKL [33] . Thus, we Figure 7B, 7E) . However, when pretreated with JSH-23, the increased expression of NFATc1 was inhibited ( Figure 7B, 7E ). These findings suggest that S. aureus may induce osteoclast differentiation through the NF-kB signaling pathway, which subsequently activates NFATc1 and determined osteoclast differentiation.
Discussion
Mature osteoclasts are derived from hematopoietic cells of the monocyte/macrophage family [26] . Recent studies have found that macrophage-colony stimulating factor (M-CSF) and receptor activator of NF-kB ligand (RANKL) play an important role in the process of osteoclast differentiation. M-CSF promotes the survival of osteoclast precursors and osteoclasts [34, 35] , and induces RANK expression in osteoclast precursors [36] , which combines with RANKL and initiates intracellular signaling pathways to regulate osteoclast differentiation [37] . In addition, RAW 264.7 cells express RANK and can differentiate into mature osteoclasts induced by RANKL [27] , and therefore play an important role in studies of osteoclast formation and function in vitro [23] .
Here, we comprehensively studied the effect of S. aureus on osteoclast differentiation, and found that S. aureus induced osteoclast differentiation and promoted bone resorption in a dose-dependent way, which was verified in live S. aureus, inactivated S. aureus, and S. aureus filtrate. This means that S. aureus, inactivated S. aureus, S. aureus filtrate, JSH-23, RANKL, and PBS for 5 days. Then, the cells were removed, and the resorption pits were photographed and analyzed with Scion image software. Data indicated the ratio of the cumulative area of resorption pits divided by the entire image area in the same field of view, and the data are shown as means ±SD. One-way ANOVA was used to compared among groups. For the groups with statistical significance, the LSD/Student-Newman-Keul test was used to compare between the 2 groups. "*" just above the column indicates the comparison with the control group, while other "*" indicates the comparison between the 2 groups, ** p<0.01, *** P<0.001. aureus promotes osteoclast differentiation through its cell wall compound and secretion of small soluble molecules. Our results are in agreement with the results of some scholars [17] , but in contrast with the results of some other studies [38, 39] . The main reason for these different results may be the difference in osteoclast precursors used in the experiments; they induce bone marrow cells with M-CSF and RANKL to obtain osteoclast precursors, but the osteoclast precursors they have obtained are early osteoclast precursors, committed osteoclast precursors, or mature osteoclasts, which have not been identified. In addition, the time of action and concentrations of M-CSF and RANKL undoubtedly affect the formation of osteoclast precursors. Live S. aureus acting on different stages of osteoclast precursors may yield different results. Here, we used RAW 264.7 cells as osteoclast precursors, which are widely used in studies of osteoclast formation and function in vitro, and this may be considered a more reasonable choice. Since bone is a dynamic organ, the balance between bone formation and bone resorption plays a major role in the maintenance of bone mineralization [10] . When we study the mechanisms of osteolytic diseases, we should not only study the effect of pathogenic factors on bone formation, but also explore the influence of pathogenic factors on bone resorption. When the effect of bone resorption is stronger than that of bone formation, bone destruction will arise. Our study found that the increase and activation of osteoclast differentiation induced by S. aureus infection is also an important cause of the formation of infectious bone defects, and the treatment methods of inhibiting osteoclast differentiation and activation may provide some help for the treatment of osteomyelitis.
In addition, we explored the molecular mechanism of S. aureus-induced osteoclast differentiation. RANKL, mainly derived from osteocytes [40] , plays an important role in osteoclast differentiation. The binding of RANKL to RANK triggers a sequence of intracellular signal transduction pathways, including NF-kB and MAPKs, as well as PI-3K/AKT signaling pathways, which evokes the activation and autoamplification of NFATc1 and determines the terminal differentiation of osteoclasts. Moreover, NF-kB induces the initial activation of NFATc1 [33] and can induce osteoclast differentiation in the absence of RANKL [41] . In the present study, we found that the degradation of IkBa and phosphorylation of NF-kB in RAW 264.7 cells stimulated with S. aureus, and the changes of these 2 proteins have a certain relevance in time, but proteins in MAPKs and PI-3K/AKT signaling pathways showed no obvious change. We also found that the high expression of NFATc1 occurred on days 2 and 3 after S. aureus treatment. These results indicate that S. aureus activates NF-kB, which subsequently activates NFATc1 and promotes osteoclast differentiation in the absence of RANKL. Thus, we used JSH-23 to inhibit the activity of NF-kB and repeated some experiments. We found that the formation of osteoclast-like cells and resorption pits was decreased, and the expression of NFATc1 and osteoclast-specific genes, such as TRAP, MMP-9, Cathepsin K, CTR, and ATP6v0d2, were inhibited, which suggests that the activation of NF-kB plays a role in S. aureus-induced osteoclast differentiation. In addition, some researchers found that NF-kB plays an important role in the expression of inflammatory cytokines [42] , and the NF-kB signaling pathway was activated in the process of S. aureus infecting osteoblasts. Combined with our experimental results, the evidence suggests that inhibitors of the NF-kB signaling pathway can be useful in the treatment of osteomyelitis. However, the mechanism by which S. aureus induces NF-kB activation needs additional research.
The autoamplification of NFATc1 in the final stage of osteoclast differentiation regulates the expression of many osteoclast-specific genes, such as TRAP [33] , MMP-9 [43] , cathepsin K, CTR, and Atp6v0d2 [44, 45] . In our research, we found that the increased expression of NFATc1 occurred at 2 days and 3 days after S. aureus stimulation, and the mRNA expression levels of TRAP, MMP-9, Cathepsin K, and Atp6v0d2 in RAW 264.7 cells treated with S. aureus were increased in a dose-dependent manner. However, when added with JSH-23, an inhibitor of NF-kB activation, the expression of NFATc1 was inhibited, and the mRNA expression of osteoclast-specific genes was also decreased, which indicates that S. aureus activated NFkB, which subsequently activated NFATc1 and promoted osteoclast differentiation.
Conclusions
Our results demonstrate that S. aureus promotes osteoclast differentiation and bone resorption through its cell wall compound and secretion of small soluble molecules, and the activation of NF-kB plays a major role in this process. Our research provides a molecular basis for understanding the pathogenesis of S. aureus-mediated osteomyelitis, which indicates that S. aureus infection not only inhibits bone formation, but also enhances bone resorption, and the formation of infectious bone defect is the effect of these 2 aspects.
